Droplet Biosciences, Inc. — Form D
Droplet Biosciences, Inc. of Cambridge, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-05-28. The offering totals $5.3M, of which $5.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-05-28
- Form: D
- Accession: 0001847243-21-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.3M
- Amount sold: $5.3M
- Investors: 30
- Date of first sale: 2021-05-21
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-401080
Issuer
- Name: Droplet Biosciences, Inc.
- CIK: 0001847243
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 750 Main Street, Cambridge, MA, 02139
- Phone: (832) 622-8454
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Aadel Chaudhuri | Director | Chesterfield, MO |
| Aadel Chaudhuri | Executive Officer | Chesterfield, MO |
| Ann DeWitt | Director | Woburn, MA |
| Rachel Sha | Director | Woburn, MA |
| Stanley Lapidus | Director | BOSTON, MA |
| Theresa Tribble | Director | Cambridge, MA |
| Theresa Tribble | Executive Officer | Cambridge, MA |
| Jose Zevallos | Director | Cambridge, MA |
Other filings by this issuer (1)
More